One area of the market that has been gaining steam: biotech stocks. A flurry of deals, FDA approvals, and recent innovations in the …
Pacira’s Exparel “Hit Where It Needed to Most” Pacira Pharmaceuticals Inc (NASDAQ:PCRX) shares were falling 12% yesterday after the drug maker’s pain medicine …
EXACT Sciences Corporation (NASDAQ:EXAS) shares rose over 10% in Wednesday’s trading session, following the news that the United Healthcare issued an updated preventative care services …
Earnings season continued to have an impact on individual stocks, and EXACT Sciences Corporation (NASDAQ:EXAS) and Paypal Holdings Inc (NASDAQ:PYPL) were among the …
Ariad Pharmaceuticals, Inc. Investors in Ariad Pharmaceuticals, Inc.
EXACT Sciences Corporation (NASDAQ:EXAS) shares fell almost 15% yesterday after the molecular diagnostics company posted third-quarter earnings yesterday. Yet, Canaccord analyst Mark Massaro …
Roth Capital analyst Chris Lewis remains neutral on molecular diagnostics company EXACT Sciences Corporation (NASDAQ:EXAS). Following solid second quarter earnings results, but with …
EXACT Sciences Corporation (NASDAQ:EXAS) announced an agreement to sell 7,000,000 shares of its common stock to Jefferies LLC, Robert W. Baird & Co.
Analyst Sean Lavin of BTIG was encouraged with EXACT Sciences Corporations (NASDAQ:EXAS) latest earnings report. EXACT’s second quarter saw an increase in the …
EXACT Sciences Corporation (NASDAQ:EXAS) announced that the company generated revenues of $21.2 million during the second quarter ended June 30, 2016, representing a …
